Werner Scheithauer
Impact in
- Hepatology top 0.1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 0.05%
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Cancer Treatment and Pharmacology
- Colorectal Cancer Surgical Treatments
Papers in
- Oncology 249
- Colorectal Cancer Treatments and Studies 156
- Cancer Treatment and Pharmacology 88
- Pancreatic and Hepatic Oncology Research 50
-
- Lung Cancer Treatments and Mutations 39
- Gastric Cancer Management and Outcomes 35
- Co-authors
- Gabriela Kornek (87 shared papers)Arié Figer (10 shared papers)Eduardo Díaz‐Rubio (14 shared papers)D. Depisch (50 shared papers)Sheryl Koski (7 shared papers)Markus Raderer (43 shared papers)Stephen Clarke (6 shared papers)Leonard B. Saltz (6 shared papers)
- Journals
- Journal of Clinical Oncology (85 papers)Annals of Oncology (37 papers)British Journal of Cancer (20 papers)European Journal of Cancer (19 papers)Oncology (13 papers)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Werner Scheithauer
330 papers receiving 17.8k citations
Werner Scheithauer's Hit Papers
Peers
Comparison fields: 5 of 145
- Hepatology 3.3k
- Oncology 11.3k
- Cancer Research 1.5k
- Pulmonary and Respiratory Medicine 3.1k
- Internal Medicine 297
Countries citing papers authored by Werner Scheithauer
This map shows the geographic impact of Werner Scheithauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Werner Scheithauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Werner Scheithauer more than expected).
Fields of papers citing papers by Werner Scheithauer
This network shows the impact of papers produced by Werner Scheithauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Werner Scheithauer. The network helps show where Werner Scheithauer may publish in the future.
Co-authors
The 25 scholars most cited alongside Werner Scheithauer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 350 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study Hit paper breakdown → | 2008 | 2286 |
| 2 | Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial Hit paper breakdown → | 2008 | 1403 |
| 3 | Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial Hit paper breakdown → | 2013 | 872 |
| 4 | EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer Hit paper breakdown → | 2008 | 728 |
| 5 | Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer Hit paper breakdown → | 2008 | 655 |
| 6 | Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer Hit paper breakdown → | 2009 | 604 |
| 7 | nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial Hit paper breakdown → | 2015 | 510 |
| 8 | Phase III Trial of Bevacizumab in Combination With Gemcitabine and Erlotinib in Patients With Metastatic Pancreatic Cancer Hit paper breakdown → | 2009 | 505 |
| 9 | Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. Hit paper breakdown → | 1993 | 494 |
| 10 | 2007 | 448 | |
| 11 | 2002 | 360 | |
| 12 | 2008 | 315 | |
| 13 | 2012 | 239 | |
| 14 | 2003 | 225 | |
| 15 | 1993 | 201 | |
| 16 | 2004 | 194 | |
| 17 | 1994 | 191 | |
| 18 | 2004 | 190 | |
| 19 | 2011 | 180 | |
| 20 | 2008 | 179 |
About Werner Scheithauer
Werner Scheithauer is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Cancer Research and Pathology and Forensic Medicine, having authored 350 papers that have together received 18.3k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (156 papers), Cancer Treatment and Pharmacology (88 papers), Pancreatic and Hepatic Oncology Research (50 papers), Lung Cancer Treatments and Mutations (39 papers), Gastric Cancer Management and Outcomes (35 papers), Cancer Genomics and Diagnostics (26 papers), Genetic factors in colorectal cancer (22 papers) and Neuroendocrine Tumor Research Advances (21 papers). The work is most often cited by research in Hepatology (3.3k citations), Oncology (11.3k citations), Cancer Research (1.5k citations), Pulmonary and Respiratory Medicine (3.1k citations) and Internal Medicine (297 citations). Werner Scheithauer has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Gabriela Kornek, Arié Figer, Eduardo Díaz‐Rubio, D. Depisch, Sheryl Koski, Markus Raderer, Stephen Clarke, Leonard B. Saltz, Jim Cassidy and Thomas Gruenberger. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, British Journal of Cancer, European Journal of Cancer and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.